Effects of melatonin in the treatment of asthenia in aneurysmal subarachnoid hemorrhage.

Fiche publication

Date publication

décembre 2016

Journal

Neuro-Chirurgie

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PROUST François

Tous les auteurs :
Gilard V, Ferracci FX, Langlois O, Derrey S, Proust F, Curey S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27865517

Résumé

Survivors of aneurysmal subarachnoid hemorrhage (aSAH) commonly experience sleep disorders resulting in asthenia. The objective of this prospective study was to determine, in a cohort of patients with treated ruptured intracranial aneurysm (IA), the proportion of asthenia at 2months, in a cohort of patients treated with melatonin and in a control cohort.